Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD
Background. Tumor necrosis factor-alpha (TNF-α) agonists revolutionized therapeutic algorithms in inflammatory bowel disease (IBD) management. However, approximately every third IBD patient does not respond to this therapy in the long term, which delays efficient control of the intestinal inflammati...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2023-01-01
|
| Seri Bilgileri: | Journal of Immunology Research |
| Online Erişim: | http://dx.doi.org/10.1155/2023/1535484 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|